Smartcardia SA
Developer of a wearable multi‑lead ECG patch and cloud SaaS platform for continuous cardiac and remote patient monitoring. The company provides real‑time full‑disclosure multi‑lead ECG streaming, automated machine‑learning arrhythmia detection trained on annotated clinical datasets, multi‑vital sensing, and clinician dashboards. The solution has been clinically validated in multiple studies and holds regulatory approvals (CE Class IIa, FDA clearances) and ISO certifications.
Industries
N/A
Nr. of Employees
small (1-50)
Smartcardia SA
EPFL Innovation Park, Building C, 1015 Lausanne, Switzerland
Patents
Products
Wearable multi‑lead ECG patch and cloud telemetry platform
A cable‑free wearable patch that records seven ECG leads and multiple vitals and streams full‑disclosure data to a clinician cloud platform for automated analysis, alerting and reporting.
Wearable multi‑lead ECG patch and cloud telemetry platform
A cable‑free wearable patch that records seven ECG leads and multiple vitals and streams full‑disclosure data to a clinician cloud platform for automated analysis, alerting and reporting.
Services
Provision of live outpatient cardiac telemetry, extended Holter, event monitoring and remote patient monitoring delivered via a cloud platform to hospitals and clinicians.
Provision of live outpatient cardiac telemetry, extended Holter, event monitoring and remote patient monitoring delivered via a cloud platform to hospitals and clinicians.
Expertise Areas
- Remote patient monitoring
- Ambulatory ECG monitoring and cardiac telemetry
- Clinical validation and comparative trials
- Machine learning for cardiac diagnostics
Key Technologies
- 7‑lead electrocardiography (ECG)
- Wearable adhesive biosensor patches
- Cloud‑based real‑time analytics and dashboards
- Machine learning for ECG interpretation
News & Updates
FDA clearance obtained for live 7‑lead ECG patch and cloud platform enabling outpatient cardiac telemetry.
FDA clearance for a 14‑day continuous 7‑lead ECG monitoring patch and cloud platform.
Appointment of a senior clinical advisor to lead medical advisory activities and provider education for digital health offerings.
Completed acquisition of a US IDTF to integrate diagnostic service delivery with the monitoring platform and establish operational control.
Published comparative study showing feasibility and fewer false alarms using a wireless continuous cardiac monitoring system versus conventional telemetry in postoperative cardiac surgery patients.
Study comparing upper arm wearable SpO2 measurements with arterial SaO2 and established finger pulse oximeters, reporting comparable accuracy in volunteers.
FDA clearance obtained for live 7‑lead ECG patch and cloud platform enabling outpatient cardiac telemetry.
FDA clearance for a 14‑day continuous 7‑lead ECG monitoring patch and cloud platform.
Appointment of a senior clinical advisor to lead medical advisory activities and provider education for digital health offerings.
Completed acquisition of a US IDTF to integrate diagnostic service delivery with the monitoring platform and establish operational control.
Published comparative study showing feasibility and fewer false alarms using a wireless continuous cardiac monitoring system versus conventional telemetry in postoperative cardiac surgery patients.
Study comparing upper arm wearable SpO2 measurements with arterial SaO2 and established finger pulse oximeters, reporting comparable accuracy in volunteers.